While genetic therapies focus on the protein defect, the "Myostatin Inhibition" sector of early 2026 is focused on "Universal Muscle Growth." Myostatin is a natural protein that tells the body to stop making muscle; by inhibiting this "Brake," researchers hope to help Duchenne patients build more muscle mass to compensate for what is lost to the disease. Despite historical setbacks in this...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
